277 related articles for article (PubMed ID: 11696356)
1. MMP-TIMP interaction depends on residue 2 in TIMP-4.
Stratmann B; Farr M; Tschesche H
FEBS Lett; 2001 Nov; 507(3):285-7. PubMed ID: 11696356
[TBL] [Abstract][Full Text] [Related]
2. Characterization of C-terminally truncated human tissue inhibitor of metalloproteinases-4 expressed in Pichia pastoris.
Stratmann B; Farr M; Tschesche H
Biol Chem; 2001 Jun; 382(6):987-91. PubMed ID: 11501766
[TBL] [Abstract][Full Text] [Related]
3. E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A).
Troeberg L; Tanaka M; Wait R; Shi YE; Brew K; Nagase H
Biochemistry; 2002 Dec; 41(50):15025-35. PubMed ID: 12475252
[TBL] [Abstract][Full Text] [Related]
4. Engineering minimal tissue inhibitors of metalloproteinase targeting MMPs via gene shuffling and yeast surface display.
Hosseini A; Kumar S; Hedin K; Raeeszadeh-Sarmazdeh M
Protein Sci; 2023 Dec; 32(12):e4795. PubMed ID: 37807423
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
6. Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors.
Nagase H; Brew K
Biochem Soc Symp; 2003; (70):201-12. PubMed ID: 14587293
[TBL] [Abstract][Full Text] [Related]
7. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
Peterson JT; Li H; Dillon L; Bryant JW
Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases and their tissue inhibitors in the developing neonatal mouse uterus.
Hu J; Zhang X; Nothnick WB; Spencer TE
Biol Reprod; 2004 Nov; 71(5):1598-604. PubMed ID: 15240428
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Matsunaga Y; Koda M; Murawaki Y
Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
[TBL] [Abstract][Full Text] [Related]
10. Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats.
Lu J; Hao J; Du H; Xiao B; Li Y; Yang X; Cui W
Cell Physiol Biochem; 2016; 39(1):47-60. PubMed ID: 27322513
[TBL] [Abstract][Full Text] [Related]
11. Correlations Between MMPs and TIMPs Levels in Aqueous Humor from High Myopia and Cataract Patients.
Jia Y; Hu DN; Sun J; Zhou J
Curr Eye Res; 2017 Apr; 42(4):600-603. PubMed ID: 28402202
[TBL] [Abstract][Full Text] [Related]
12. Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis.
Fielitz J; Leuschner M; Zurbrügg HR; Hannack B; Pregla R; Hetzer R; Regitz-Zagrosek V
J Mol Med (Berl); 2004 Dec; 82(12):809-20. PubMed ID: 15558223
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-10/TIMP-2 structure and analyses define conserved core interactions and diverse exosite interactions in MMP/TIMP complexes.
Batra J; Soares AS; Mehner C; Radisky ES
PLoS One; 2013; 8(9):e75836. PubMed ID: 24073280
[TBL] [Abstract][Full Text] [Related]
15. Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations.
Hashimoto T; Wen G; Lawton MT; Boudreau NJ; Bollen AW; Yang GY; Barbaro NM; Higashida RT; Dowd CF; Halbach VV; Young WL;
Stroke; 2003 Apr; 34(4):925-31. PubMed ID: 12649522
[TBL] [Abstract][Full Text] [Related]
16. Relationship between matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases systems and autoantibody patterns in systemic sclerosis.
Montagnana M; Volpe A; Lippi G; Caramaschi P; Salvagno GL; Biasi D; Bambara LM; Guidi GC
Clin Biochem; 2007 Aug; 40(12):837-42. PubMed ID: 17493602
[TBL] [Abstract][Full Text] [Related]
17. Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium.
Goffin F; Munaut C; Frankenne F; Perrier D'Hauterive S; Béliard A; Fridman V; Nervo P; Colige A; Foidart JM
Biol Reprod; 2003 Sep; 69(3):976-84. PubMed ID: 12773401
[TBL] [Abstract][Full Text] [Related]
18. Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle.
Young KA; Hennebold JD; Stouffer RL
Mol Hum Reprod; 2002 Sep; 8(9):833-40. PubMed ID: 12200461
[TBL] [Abstract][Full Text] [Related]
19. Disequilibrium in MMPs and the tissue inhibitor of metalloproteinases in different segments of the varicose great saphenous vein wall.
Hu X; Hu F; Xu Y; Tang J; Chu H; Zhong Y
Int Angiol; 2019 Jun; 38(3):185-193. PubMed ID: 31058480
[TBL] [Abstract][Full Text] [Related]
20. Dynamic interdomain interactions contribute to the inhibition of matrix metalloproteinases by tissue inhibitors of metalloproteinases.
Remacle AG; Shiryaev SA; Radichev IA; Rozanov DV; Stec B; Strongin AY
J Biol Chem; 2011 Jun; 286(23):21002-12. PubMed ID: 21518756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
